Ursodeoxycholic Acid and Parkinson's Disease Risk: An Emulated Target Trial in UK Electronic Health Records

More on Parkinson's disease

• Disrupted sphingolipid metabolism drives lysosomal and mitochondrial failure in Parkinson's disease

  bioRxiv · 2 Oct 2026

  

• Ultrafine particle exposure linked to dementia mortality

  Epidemiology · 5 Oct 2026

  

• Lewy body disease tracks with cognitive decline and psychosis

  Movement Disorders · 4 Oct 2026

• Sephin1 promotes mitophagy and reduces alpha-synuclein toxicity in Parkinson models

  Biochemical Pharmacology · 2 Oct 2026